Complications of Radiofrequency Ablation of Hepatic, Pulmonary, and Renal Neoplasms

Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms

Health technology The health technology examined in the study was radiofrequency (RF) ablation, a minimally invasive technique for the treatment of malignant liver neoplasms, in particular hepatocellular carcinoma (HCC) and colorectal liver metastases (CLM). Percutaneous RF ablation involves the insertion of one or more electrodes into the tumour nodule under imaging guidance. A high-frequency ...

Cost-effectiveness of percutaneous radiofrequency ablation for malignant hepatic neoplasms.

PURPOSE Percutaneous radiofrequency (RF) ablation is a promising technique for the treatment of hepatic malignancies. However, its cost-effectiveness has not been established. The purpose of this study is to determine the cost-effectiveness of RF ablation compared to palliative care in the treatment of hepatocellular cancer and colorectal liver metastases. This study also seeks to evaluate the ...

Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm.

BACKGROUND Thermal ablation of unresectable hepatic tumors can be achieved by cryosurgical ablation (CSA) or radiofrequency ablation (RFA). The relative advantages and disadvantages of each technique have not yet been determined. HYPOTHESIS Radiofrequency ablation of malignant hepatic neoplasms can be performed safely, but is currently limited by size. Cryosurgical ablation, while associated ...

Hepatic radiofrequency ablation.

HYPOTHESIS Hepatic radiofrequency ablation (RFA) is effective in treating patients with unresectable hepatic malignancies. DESIGN Case series of 123 patients with unresectable hepatic tumors or tumors with histological findings not traditionally treated by means of hepatic resection were considered for hepatic RFA. Median follow-up was 20 months. SETTING Tertiary referral center. PATIENTS...

Radiofrequency ablation of renal tumours